Kazakhstan was the first among the CIS countries to implement the latest technology for treating cardiac arrhythmias. Specialists from the UMC Heart Center successfully implemented Farapulse electropulse ablation, an advanced method for treating cardiac arrhythmias that is used in leading clinics around the world. The technology is highly safe and effective, and the recovery time for patients after the procedure is reduced to 1-2 days.

A master class on the use of the new technology was conducted by world-famous cardiologist, Professor Serge Boveda from the French clinic Clinique Pasteur, who is also the secretary of the European Heart Rhythm Association (EHRA).

“The procedure is minimally invasive – a catheter is inserted through the femoral vein and directed to the heart, where it affects only pathological tissues using electroporation. The entire process takes no more than an hour, and patients can return to normal life in a couple of days,” the professor said.

Farapulse technology was introduced in Kazakhstan for the first time among the CIS and Central Asian countries. It is used when patients develop atrial fibrillation - a rapid and irregular contraction of the upper chambers of the heart. UMC Heart Center specialists performed 8 procedures during the master class, under the guidance of Dr. Boveda.

“The technology allows for targeted action on arrhythmia zones without affecting healthy tissues, which makes the treatment as safe as possible for the patient,” said Omirbek Nuralinov, Head of the Interventional Arrhythmology Department at UMC Heart Center.

The introduction of this technology is especially relevant, since cardiovascular diseases remain one of the leading causes of death in the world.

“In Kazakhstan, about 1,000 patients need treatment for atrial fibrillation every year, and thanks to the state quota, they will be able to receive this high-tech care free of charge,” said Yuri Pya, Chairman of the Board of UMC.

gov.kz

translated by Qazalem